Completed NA INTERVENTIONAL 4-arm NCT03738137

Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy

Narcotrend Versus Bispectral Index Monitoring During Sufentanil-Midazolam Anesthesia for Bronchoscopy Under Conscious Sedation

Sponsor: Guangzhou Institute of Respiratory Disease

Conditions Bronchoscopy

Interventions BIS Lidocaine Midazolam Narotrend Sufentanil

Updated 5 times since 2018 Last updated: Apr 2, 2019 Started: Aug 1, 2018 Primary completion: Jan 15, 2019 Completion: Jan 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03738137, this NA trial focuses on Bronchoscopy and remains completed. Sponsored by Guangzhou Institute of Respiratory Disease, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Dec 2018 — May 2019 [monthly]

Recruiting NA

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou Institute of Respiratory Disease

Data source: Guangzhou Institute of Respiratory Disease

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China